Skip to main content

Celularity Inc

CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001752828

No open-market purchases or sales by Celularity Inc insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $2.44M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Celularity Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CELU: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders021+21
Shares01.19M+1.19M
Value$0$8.42M+$8.42M

New holders (21)

Institutions that held Celularity Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CELU in Q3 2021
InstitutionSharesValue% of portfolio
FMR LLC644,600$4.56M0.00%
HRT Financial LP144,837$1.02M0.01%
Geode Capital Management, LLC66,554$471.0K0.00%
Morgan Stanley51,000$361.0K0.00%
Verition Fund Management LLC50,000$354.0K0.01%
Lombard Odier Asset Management (USA) Corp40,000$283.0K0.04%
Citadel Advisors LLC33,474$237.0K0.00%
Jane Street Group, LLC30,636$217.0K0.00%
BlackRock Inc.25,305$179.0K0.00%
Group One Trading, L.P.21,249$150.0K0.00%
Caption Management, LLC20,000$142.0K0.01%
Millennium Management LLC15,385$109.0K0.00%
Penserra Capital Management LLC12,566$88.0K0.00%
Marshall Wace, LLP12,291$87.0K0.00%
Cutler Group LP9,743$68.0K0.01%
Captrust Financial Advisors3,000$21.0K0.00%
UBS Group AG2,898$21.0K0.00%
Bank of America Corp2,223$16.0K0.00%
Citigroup Inc1,449$10.0K0.00%
Harbour Investments, Inc.1,200$8.00K0.00%
Valley National Advisers Inc1,000$7.00K0.00%

Sold out (0)

Institutions that held Celularity Inc at the end of Q2 2021 and filed for Q3 2021 without it.

None.